Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × Magnetic Resonance Imaging × Clear all

Sponsor

Conditions

Prostatic Neoplasms 8 Breast Neoplasms 7 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Lymphoma, B-Cell 2 Liver Neoplasms 2 Leukemia 2 Carcinoma, Hepatocellular 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vasculitis 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Papillomavirus Infections 1 Osteomyelitis 1 Neurofibromatosis 1 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Sclerosis 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 poly ICLC 2 palbociclib 2 etoposide phosphate 2 Vincristine 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 temsirolimus 1 tandutinib 1 selinexor 1 romidepsin 1 picropodophyllin 1 pemigatinib 1 niraparib 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡